Avaí Bio, Inc. (OTCQB: AVAI) ("Avaí" or the "Company"), an emerging biotechnology company developing transformative cell-based therapies for diabetes, age-related disorders, and anti-aging, today ...

Tourmaline Bio, Inc. will host a conference call and webcast on May 20, 2025, at 8:30 a.m. ET to share topline results from the Phase 2 TRANQUILITY trial of pacibekitug in patients with chronic kidney ...

MINNEAPOLIS, July 17, 2025 /PRNewswire/ -- Bio-Techne Corporation (TECH) today announced that management will host a conference call and webcast on Wednesday, August 6, 2025, at 8:00 a.m. CDT to ...

Bio-Path Holdings will host a conference call on May 29, 2025, to discuss its business overview and pipeline developments. Bio-Path Holdings, Inc., a biotechnology company focused on developing cancer ...

On Monday, 09 March 2026, Belite Bio (NASDAQ:BLTE) presented at the Leerink Global Healthcare Conference 2026, unveiling promising Phase 3 trial results for Tinlarebant, an oral treatment for ...

MINNEAPOLIS, Oct. 15, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, November 5, 2025, at 8:00 a.m.

BOSTON, March 5, 2026 /PRNewswire/ -- Cambridge Healthtech Institute today announced the agenda for the third annual Bio-IT World Venture, Innovation & Partnering Conference, an exclusive gathering of ...

MINNEAPOLIS, Jan. 20, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, February 4, 2026, at 8:00 a.m.

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Good morning, everyone. Thank you for standing by, and welcome to BIO-key International's Second Quarter 2025 Call. [Operator Instructions] As a reminder, this conference is being recorded today, ...

GREENSBORO, N.C., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Precise Bio, Inc. (“Precise Bio” or the “Company”), a clinical-stage regenerative medicine company pioneering bio-printed tissues and organs with an ...

NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder, ...